# Lineage Cell Therapeutics, Inc.: Form DEF 14A, filed Aug 3, 2021

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: DEF 14A
- Filed: 2021-08-03
- Accepted by EDGAR: Aug 3, 2021, 17:00 ET
- Period: 2021-08-03
- Accession: 0001493152-21-018445
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315221018445/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315221018445/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315221018445/formdef14a.htm

Filed Aug 3, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-018445. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
